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   Hemoglobin was obtained from blood of adult white leghorns. It was 
first separated into three components, AI, AII, and AIII by CMC-column 
chromatography. AII, the greatest component of the three was chosen as 
the subject matter of the present study. It was first converted into globin 
by removal of heme in acetone-HCl solution, and then the globin was se-
parated　 into　 α　andβ 　polypeptide　 chains　 by　 Amberlite　 CG50　 column　 chrom-
atography.　 The　 α　polypeptide　 chain　 was　 digested　 with　 trypsin,　 and　 tryptic
peptides thus obtained were subjected to column chromatography and then 
to paper chromatography for isolation and purification. The column chro-
matography was carried out by using Dowex 1X2 as the adsorbent and 
the acetate buffer containing organic bases such as pyridine, collidine, 
lutidine, and picoline as the developer. The developer for the paper chro-
matography was the mixture of n-butanol, acetic acid, and water. 
   The amino acid composition of the tryptic peptides thus isolated and 
purified was analyzed on an amino acid analyzer and subsequently the 
amino acid sequence in these tryptic peptides was determined by using 
partial hydrolyses with various enzymes, the PTC method, and the DNP 
method. The results were discussed in comparison with human hemoglo-
bin. As a result, replacement of amino acids in the tryptic peptides be-
tween adult human and white leghorn hemoglobins was presumed at 35
positions　 in　the　 α　polypeptide　 chain.
                  INTRODUCTION 
   With the recent progress of protein chemistry, attempts to elucid-
ate problems on evolution and phylogeny of living organisms on mole-
cular level have extensively been made since 1950. Above all, since 
amino acid sequence in protein molecules, i. e. the primary structure 
of proteins was known to be a precise copy of the hereditary message 
of DNA in cell nucleus, a great importance has been placed on the 
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comparative studies on the primary structures of protein molecules 
from living organisms belonging to different species because they 
give some clues for phylogeny. 
   According as the advance in theories of protein chemistry and 
analytical techniques prompt many groups of workers to uudertake 
investigations on the primary structure, information on the correlation 
between the primary structure and its biological function was also der-
ived. It was confirmed that the two living organisms belonging to 
considerably remote species possess some kinds of protein whose pri-
mary structure as well as biological function is remarkably similar to 
each other, and this fact elicited a hypothesis that such proteins are 
due to a common ancestral gene possessed by the both. 
   On the other hand, it is generally presumed that in proteins with 
the biological activity, a certain part of the primary structure plays a 
much more important role than other parts, and therefore, if the 
amino acid sequence in this important part is unchanged, proteins do 
not lose their function even though there exist some differences in 
the amino acid sequence of other parts. 
   For promoting the studies as stated above, hemoglobin is one of the 
most useful experimental materials not only because it can be found 
very commonly in the animal kingdom but because it can be isolated 
and purified relatively more readily than other proteins. Since BRAUN-
ITZER et al.9) and KONIGSBERG et al.24) established the primary structure 
of human hemoglobin, many groups of workers in the world have 
studied8),13),44),52) or are study in g4).38),40),45) on the primary structure 
of mammlian hemoglobins from various species. In 1968, MATSUDA et 
al.31) of our department determined the whole primary structure of 
adult rhesus monkey hemoglobin. With respect of non-mammalian he-
moglobins, however, BRAUNITZER et al, 21) only reported the determin-
ation of the primary structure of the a polypeptide chain of carp he-
moglobin, and no reports have been presented on avian hemoglobins. 
   Our department, with an interest in the phylogenetic relationship 
between human and Chicken hemoglobins as well as their resemblance 
in function such as Bohr's effect and the oxygen dissociation curve, 
have been investigating on the primary structure of adult hemoglobin 
of the Chicken. 
   As a first step, the present author determined the amino acid se-
quence in all the tryptic peptides from the r>a polypeptide chain of the 
greatest component, All of adult Chicken hemoglobin and compared 
the results with the known sequence of human hemoglobin. 
             MATERIALS AND METHODS 
1) Preparation of Hemoglobin from Adult Chickens. 
   Hemoglobin solution was obtained by DRABKIN' S method17) from
blood of adult pure-line white leghorns (Smal A type) as follows. 
    Blood was obtained from the jugular vein of white leghorns, and 
to this was added 3.8% sodium citrate solution as an anticoagulant. 
The blood was then submitted to centrifugation in order to remove 
plasma and then to this was added an equal volume of deionized water 
and half the volume of toluene. The mixture was hemolyzed overnight 
in the cold (2° to 4°). The hemolysate was centrifuged at 12,000 r.p. 
m. for 1 hour at 0', and the hemoglobin solution was obtained. 
2) Isolation of All Component from the Hemoglobin Solution. 
   All component was isolated from the hemoglobin solution according 
to MATSUDA et al.32) 
   The activated carboxymethyl cellulose(Brown Company, 0.71 mEq/g) 
was poured into a column (2 x 30 cm), which was equilibrated with 
0.01 M phosphate buffer, pH 6.9, The hemoglobin solution, 5 ml, was 
placed on the column. The linear gradient elution was carried out by 
means of phosphate concentration. The fraction volume was 25 ml. The 
optical density of the effluent was measured at 542 mp and 280 ma. 
Fractions at each peak were combined, dialyzed against deionized wa-
ter, and finally lyophilized. 
3) Preparation of Globin. 
   Removal of heme from All component was performed according to 
ANSON and MIRSKY.2) The lyophilized All component, about 5,000 mg, 
was added dropwise with stirring to HC1-acetone solution cooled at 
-20' . The solution was centrifuged at 3,000 r . p . m . for 5 min at 00 to 
40, dissolved in an appropriate volume of deionized water, dialyzed 
against deionized water, and finally lyophilized. 
4) Isolation of a Polypeptide Chain from the Globin of All Component. 
   The globin obtained from All component was separated into a and 
13 polypeptide chains by the method of SuiTx5o) and MATSUDA et al.29) 
The column (3.3 x 45 cm) was prepared with the activated Amberlite 
CG50 (Type II, H-form) and then equilibrated with 3N formic acid. To 
this column was applied 1,000 mg of the globin from All component. 
The linear gradient elution was performed by means of urea concen-
tration. The fraction volume was 25 ml. The effluent was analyzed by 
optical density at 280 mid. Fractions at each peak were combined, dialy-
zed against deionized water, and then lyophilized. 
5) Determination of the N-Terminal Structure of the (i Polypeptide Chain by 
   the DNP Method. 
   The DNP method was carried out as described by MATSUDA et al.30) 
   The a polypeptide chain, 100 mg, was dinitrophenylated and DNP-
peptides thus obtained were hydrolyzed with constant boiling HCl and 
extracted with ether. The extracts were placed on a silica gel-Celite
column (1 x 15 cm). Development was performed with the mixture of 
acetic acid, acetone, and ligroin. 
6) Determination of Cysteine Residues in the (,-/ Polypeptide Chain. 
   Estimation of cysteic acids derived from cysteine residues in the a 
polypeptide chain was carried out according to MooRE33). 
   The ,, polypeptide chain, 5 umoles (85 mg), was oxidized with per-
formic acid by the method of HIRE22), and then hydrolyzed with cons-
tant boiling HCl for 18 hours. The hydrolysate was placed on a column 
(0.9 x 50 cm) of the activated Amberlite CG 120 equilibrated with 0.2 
N sodium citrate buffer, pH 3.25. Elution was carried out by using 0.2 
N sodium citrate buffer, pH 3.25, as a developer. Analysis of the efflu-
ent was performed both by the ninhydrin reaction according to MOORE 
et al.34) and by measuring the optical density at 570 m,m. 
7) Determination of Tryptophan Residues in the a Polypeptide Chain. 
   Estimation of tryptophan was carried out according to KOSHLAND et 
al. 3). 
   The a polypeptide chain, 10 umoles (170 mg), dissolved in 10 M 
urea was incubated at 37° for 16 hours, and to this was added HNB-
bromide. The a polypeptide chain thus treated was placed on a column 
(1,0x23 cm) of the activated Sephadex G-25 equilibrated with 10 M 
urea, pH 2.7. Elution was carried out with the developer, 10 M urea, 
pH 2.7. The fraction volume was 2 ml. Optical density of the effluent 
was measured at 410 ma. 
8) Digestion of the a Polypeptide Chain with Trypsin. 
   The a polypeptide chain, 1,500 mg, was denatured by the method 
of BRAUNITZER et a1.26) and then digested at 370 for 4 hours by the add-
ition of trypsin (Worthington Biochemical Co., twice crystallized) pre-
pared according to REDFIELD et al. 39) and BRAUNITZER et al.14) . After 
the termination of the digestion, the digest was adjusted to pH 6.1. 
Then, the so-called insoluble tryptic peptide was precipitated. The 
digest was submitted to centrifugation so that it was separated into the 
soluble tryptic peptides and the insoluble tryptic peptide, both of which 
were lyophilized, respectively. 
9) Column Chromatography of the Soluble Tryptic Peptides. 
   MALTA'S method27) was used. The activated Dowex 1X2 (200 to 
400 mesh, Dow Chemical Co.) was poured in a column (0.9 x 150 cm), 
which was equilibrated with 1% pyridine, 1% collidine acetate buffer, 
pH 9.0. The soluble tryptic peptides dissolved in deionized water were 
placed on the above-prepared column. The pH linear gradient elution 
was carried out by using both pyridine, 2-4 lutidine, a-picoline acetate 
buffer and acetic acid; Fraction No.1 to 20 were eluted with the star-
ting buffer, 1% pyridine, 1% collidine acetate buffer, pH 9.0 ; for
Fraction No.21 to 40, the buffer was changed. stepwise into 1% pyri-
dine, 1,°o collidine acetate buffer, pH 8.5 ; Fraction No. 41 to the 
fraction at pH 5.5 were eluted by supplying 0.1 N acetic acid in the 
upper chamber to the mixing chamber containing 1,500 ml of 1% 
pyridine, 1% picoline, 1% 2-4 lutidine acetate buffer, pH 7.5 ; To 
the fraction the effluent of which lowered to pH 3.5, 1 N acetic acid 
was supplied, and finally glacial acetic acid was used. 
   An aliquot of each fraction after the alkali-hydrolysis was submitted 
to the ninhydrin reaction according to the method of YEMM and COCK-
ING51), and then optical density was measured at 570 mp. Fractions 
at the peaks were combined respectively and dried below 370 under 
reduced pressure on a rotary evaporator. Each of the dried samples 
was dissolved in 3 ml of deionized water. Some peptides insoluble in 
water were dissolved in 50% acetic acid solution by the final acetic acid 
concentration of 12 to W/06). 
10) Digestion of the So-Called Insoluble Tryptic Peptide with Pepsin. 
   The insoluble tryptic peptide was oxidized with performic acid by 
the method of HIRs22). Digestion was carried out at 37° for 2 hours by 
adding pepsin (Sigma Chemical Co., Three time crystallized) by a 
ratio of 1% to the substrate. At the termination of the digestion, the 
digest was adjusted to pH 10.0 and the dried under reduced pressure 
below 37'. Column chromatography for the insoluble tryptic peptide 
was carried out in the same way as for the soluble tryptic peptides. 
11) Digestion of the Peptides, a TVI-b, a TVII-a, and a TIX-a with Pepsin. 
   Each of these peptides, about 10 pmoles, was dissolved in deionized 
water, and to this was added HCl solution containing pepsin (Sigma 
Chemical Co., three time crystallized). a TVI-b, a TVII-a, and a TIX-
a were digested at 37° for 6 hours, 4 hours, and 16 hours, respecti-
vely. The digests were adjusted to pH 10.0 and dried under reduced 
pressure. 
   A column (0.9 x 60 cm) was prepared with the activated Dowex 1 
X2 (200 to 400 mesh) and equilibrated with 1% pyridine, 1%2-4 lutidine 
acetate buffer, pH 8.5. To this column was applied the above-prepared 
peptic peptides, and then development was performed at a flow rate 
of 60 ml per hour by using the pH linear gradient elution with both 
1% pyridine, 1% 2-4 lutidine acetate buffer and acetic acid; Fractions 
No. 1 to 15 were eluted with the starting buffer, 1% pyridine, 1% 2-4 
lutidine acetate buffer; until the pH of the effluent lowered to 6.0, 
0.1 N acetic acid was supplied from the upper chamber to the mixing 
chamber containing 700 ml of the starting buffer; until the pH of the 
effluent lowered to 3.5, 1 N acetic acid was supplied and finally glacial 
acetic acid was used. During the development, the column was kept at 
37'. The effluent was collected into 8 ml-fractions by a fraction collector.
   An aliquot of each fraction was submitted to the ninhydrin rea-
ction5l) and optical density was measured at 570 mi. Fractions at each 
peak were combined together, dried under reduced pressure below 37°, 
and then dissolved in 3 ml of deionized water. 
12) Paper Chromatography of the Tryptic Peptides and the Peptic Peptides 
   from the So-Called Insoluble Tryptic Peptide and a T VI-b , u T VII-a , and 
    ai TIX-a. 
   The sample, 50 pl, was applied as a spot on a sheet of Toyo filter 
paper No. 50 (60 x 60 cm). Development was carried out at 25° in the 
constant temperature room by the descending method with the upper 
phase of the mixture of n-butanol, acetic acid, and water (4 : 1 : 5, 
V/V)36) 
   Peptides were detected by spraying 0.2% ninhydrin-n-butanol solu-
tion on the paper and then heating to color with an iron. The EHRLICH 
reaction46), the SAKAGUCHI reaction23), the PAULY reaction47), and the 
a-nitrosonaphtol reaction') were also performed on the paper. 
   Purification of peptides by paper chromatography was performed 
as follows; Peptides were detected with 0.02% ninhydrin-n-butanol 
solution and then eluted with 5% acetic acid solution for 16 hours at 
the room temperature. The eluate was dried under reduced pressure. 
13) The PTC Metho i . 
   A modification of EDMAN'S original method24) was employed for 
phenyl isothiocyanation of the peptides. The ring-formation was per-
formed by using trifluoroacetic acid (the special grade). Analysis was 
carried out by the degradation method. 
   The peptides were dissolved in 2.0 ml of 66% pyridine solution 
contained in a heart-shaped flask. To this was added 0.05 ml of pheny-
lisothiocyanate (PTC). The mixture was allowed to react at pH 7.5 
and 37° for 2 hours and then dried under reduced pressure below 37'. 
The flask was connected to the cold finger condenser and evacuated 
at 40° for 40 min in a water bath by a vacuum pump. To this was 
added 1 ml of trifluoroacetic acid. The mixture was allowed to stand 
for 4 hours at the room temperature, dried under reduced pressure 
below 37'. It was dissolved in deionized water and extracted three 
times with 5 ml of benzene. An aliquot of the aqueous phase dried 
under reduced pressure was hydrolyzed with constant boiling HC1 at 
105° for 20 hours, and the amino acid composition of the hydrolysate 
was analyzed. 
   The remainder of the aqueous phase was dried under reduced 
pressure and used for the next stage of the PTC method. 
14) N-Terminal Analyses of the Peptides by the DNP Method. 
   LLVY's method25) was employed. The peptides were dinitrophenyl-
ated at 40° for 2 hours in 1% NaHCO3 solution. After the reaction
stopped, the excess of 1-fluoro-2, 4-dinitrobenzene (DNFB) was removed 
by ether extraction. The aqueous was dried under reduced pressure 
and then hydrolyzed with constant boiling HC1 at 105° for 20 hours. 
N-terminal DNP-amino acid was extracted with ether and identified by 
the two dimensional paper chromatography. Developers were n-butanol 
saturated with 1 N NH4 OH. for the first dimension and 0.5 M phosph-
ate buffer for the second. Quantitative analysis of the DNP-amino acid 
was performed in the following way; Yellow spots on the paper chro-
matogram were cut out and extracted with 5 ml of warm water, res-
pectively. The optical density of the eluate was measured at 360 m,a. 
15) Peper Electrophoresis of the Peptides. 
   In order to know electric charge of the peptides and to distinguish 
acidic amino acid from their amides, high voltage paper electrophoresis 
was carried out at 2 KV for 2 hours on an electrophoretic apparatus 
(Ishidai type), the sample being applied on the center of a sheet of 
Toyo filter paper (10 x 60 cm), No. 50. Pyridine acetate buffer, pH 6.4 
(pyridine : acetic acid : water = 100 : 4 : 900, v/v) was used as a 
developer4l). After the paper was dried in the air, peptides were dete-
cted by spraying 0.2% ninhydrin-n-butanol solution and then heating 
to color with an iron. 
16) Amino Acid Analyses of the Peptides. 
   The purified peptides dissolved in constant boiling HC1 were hydr-
olyzed at 105° for 20 hours in a sealed tube. The hydrolysate was dried 
under reduced pressure, and then the amino acid composition was an-
alyzed on Hitachi KLA-2 amino acid analyzer. 
                     RESULTS 
1) Isolation of All Component from Hemoglobin Solution. 
   Fig. 1 shows three peaks, which were designated AIII, Al, and 
All in the elution order. Their yields were 4.8%, 23.8%, and 71.4%, 
respectively. The recovery was 87%. MANWELL28) also obtained almost 
the same results. 
2) Isolation of a and p polypeptide chains 
   The yield of the a polypeptide chain was 44% and that of the Q 
polypeptide chain, 56%. The recovery was about 60%. 
3) Determination of the N-Terminal Structure of the a Polypeptide Chain by the 
   DNP Method. 
   The N-terminal analysis of the a polypeptide chain resulted in 0.53 
mole of DNP-Val, 1.73 mole of DNP-Val-Leu, and none of DNP-Val-
His, indicating that the a polypeptide chain had been isolated almost 
in purity as previously reported by MATSUDA et al.31)
                   VOLUME OF EFFLUENT (ml) 
Fig. 1. Column chromatogram of adult chicken hemoglobin. 
         CM-Cellulose column : 2 x 30 cm. Absorbance at 542 mu ....... Absorbance 
       at 280 mu.
                       TUBE NUMBER 
Fig. 2. Separation of globin from All Component into a and (3 subunits. Column: 
       IRC-50 (l'ype II), 3.3 x 45 cm.
4) Determination of Cysteine Residues as Cysteic Acid in the -, Poly peptide Chain. 
   Estimation of cysteic acid resulted in 1.40 mole per one molec-
   ule of the a polypeptide chain. 
5) Determination of Tryptophan Residues in the a Polypeptide Chain. 
   Estimation of tryptophan resulted in 0.14 mole per one molecule of 
the (i polypeptide chain. 
6) Column Chromatography, Paper chromatogrophy, and Amino Acid Corn-
   position of the Soluble Tryptic Peptides from the a Polypeptide Chain. 
   Nine peaks were obtained as shown in Fig. 3.
                            TUBE NUMBER 
    Fig. 3. Separation of the tryptic peptides from the a polypeptide chain of All 
            component of adult chicken hemoglobin. 
   Each peak was submitted to paper chromatography. The result 
was given in Fig. 4, where 17 main spots were observed. Four of 
these spots were positive to the SAKAGUEHI reaction ; seven spots pos-
itive to the PAULY reaction ; four spots positive to the a-nitrsonaphtol 
reaction and none positive to the EHRLICH reaction. Table I gives the 
amino acid composition of these spots. (i TII-a and a T111-a, a T111-c 
and a TIV-c were identical in the amino acid composition, respectively. 
7) Sequence Analyses of the Soluble Tryptic Peptides from the a,. Polypeptide 
   Chain. 
   Amino acid sequence in each tryptic peptide was analyzed by using 
the DNP method and the PTC method together. 
(1) a TI-a (Rf Leu 0.59) 
   The N-terminal residue was known to be leucine by the DNP met-
                     PEAK NUMBER IN FIG. 3 
Fig. 4. Paper chromatogram of the tryptic peptides from the a polypeptide chain 
       of All Component of adult chicken hemoglobin. 
 Table I Amino acid compositions of the tryptic peptides 
          from the a polypeptide chain of All Component of 
         adult chicken homoglobin
     la IIa IIb IIlb I IIIc IIId IVa IVd Va Vb via VIb VIIa VIIIb IXa 
Lys 1.03 1.00 1.02 1.02 1.01 1.08 '0.98 1.07 1.06 1.12 1.92 0.98 0.93 
His 1.02 2.03 0.94 1.88 1.08 1.'02 1.06 
Arg 0.90 1.09 
Cys 
Asp 2.08 2.26 1.12 2.17 1.18 1.09 2.88 2.81 
Thr 2.03 1.02 0.93 0.90 0.90 0.94 
Ser 0.86 0.88 0.71 1.83 1.74 1.82 
Glu 1.03 1.07 1.01 4.01 
Pro 0.71 0.96 0.95 
Gly 2.03 1.21 1.08 1.10 0.97 0.98 1.96 
Ala 1.16 1.10 0.97 1.21 4.93 4.84 3.00 
Val 0.92 0.92 1.98 0.63 1.15 0.91 
Met + i 
Ileu 1.15 0.95 0.91 2.96 2.93 0.94 
Leu 1.10 0.78 1.90 0.98 1.14 2.08 2.02 1.05 
Tyr 0.91 0.72 0.76 
Phe 0.81 0.94 0.88 1.65
  hod. The sequence is Leu-Arg. D indicates the DNP method hereafter. 
D 
  (2) a TII-a (Rf Leu 0.07) 
     The following result was obtained by the PTC method. 
              Lys His Gly 
  composition 1.03 1.02 2.03 
  stage 1 1.00 0.92 1.08 
        2 1.00 0.30 1.00 
  The squence is, therefore, Gly-His-Gly-Lys. P indicates the PTC 
   method hereafter. --> - ) 
                       P P
  (3) a TII-b (RfLeu 0.18) 
     It was confirmed to be a single lysine by the descending paper 
  chromatography and amino acid analyzer. 
  (4) a TIII-b (Rf Leu 0.24) 
     The following result was obtained by the PTC method. 
               Lys Asp Val 
  composition 1.02 2.08 0.92 
  stage 1 n . d . 1.17 0.83 
         2 n.d. 0.66 1.00 
  n . d . indicates "not determined", hereafter. The sequence was there-
  fore determined to be Asp-Asp-Val-Lys. 
                 P P 
  Distinction between acidic amino acids and their amides was hereafter 
  performed by paper electrophoresis. 
  (5) a TIII-c (Rf Leu 0.50) 
     The N-terminal amino acid turned out to be tyrosine by the DNP 
  method. The sequence was Tyr-Arg. 
D 
  (6) a TIII-d (Rf Leu 0.71) 
     Analysis by the PTC method resulted as follow; 
              Lys Thr Pro Gly MetO2 Ileu Phe 
  Composition 1.02 2.03 0.71 1.21 + 1.15 1.81 
  stage 1 n . d . 2.18 0.86 0.88 - 1.22 1.83 
         2 n.d. 2.10 0.93 0.86 -- 1.03 0.84
         3 n.d. 2.09 1.08 0.91 - 0.07 0.91 
         4 n.d. 2.08 0.97 0.02 - 0.00 0.91
         5 n.d. 2.08 0.93 0.00 - 0.00 0.12
        6 n.d. 2.00 0.23 0.00 - 0.00 0.00
The sequence was, therefore, Met-Phe-Ileu-Gly-Phe-Pro-Thr-Thr-Lys. 
                       P P P P P P 
(7) aTIV-a (Rf Leu 0.22) 
   The following result was obtained by the PTC method. 
             Lys Asp Ser Ala Val Leu 
composition 1.01 2.26 0.86 1.16 0.92 0.78 
stage 1 n.d. 2.04 0.86 1.18 0.00 0.78 
      2 n.d. 2.12 0.84 1.04 0.00 0.00 
      3 n.d. 1.85 0.08 1.07 0.00 0.00 
      4 n . d . 1.02 0.00 0.98 0.00 0.0-0 
      5 n.d. 1.00 0.010 0.00 0.00 0.00 
The sequence was determined to be Val-Leu-Ser-Asn-Ala-Asp-Lys 
                          P P P P P 
(8) a TIV-d (Rf Leu 0.68) 
   Analysis by the PTC method gave the following result. 
            Lys Thr Gly Ileu Phe
composition 1.08 1.02 1.08 0.95 0.94 
stage 1 n . d . 1.07 0.00 0.98 0'.95 
      2 n . d . 0.92 0.00 0.00 1.08 
      3 n . d . 1.00 0.00 0.00 0.12 
The sequence was therefore determined to be Gly-Ileu-Phe-Thr-Lys. 
                                  P P P
(9) aTV-a (Rf Leu 0.20) 
   The following result was obtained by the PTC method. 
            Lys His Asp Ser Ala Leu 
composition '0.98 2.03 1.12 0.88 1.10 1.90 
stage 1 n.d. n.d. 1.21 0.81 1.11 0.90 
      2 n.d. n.d. 1.21 0.18 1.07 0.73 
      3 n.d. n.d. 0.35 0.05 1.00 0.78 
      4 n.d. n.d. 0.00 0.00 1.00 0.18 
       5 n.d. n.d. 0.00 0.00 1.00 0.-00 
       6 n.d. n.d. 0.-00 0.00 0.28 0.00 
The sequence was therefore Leu-Ser-Asp-Leu-His-Ala-His-Lys. 
                        > > > > 
                     P P P P P P 
(10) aTV-6 (Rf Leu 0.61) 
   It was analyzed by the PTC method as follows. 
            Lys Asp Pro Val Phe 
composition 1.07 2.17 0.96 1.98 0.88 
stage 1 n . d . 2.05 0.86 1.06 1.00 
      2 n.d. 1.24 0.79 0.95 1.01
      3 n.d. 1.14 0.16 0.97 0.88 
      4 n.d. 1.15 0.00 0.13 0.85 
      5 n.d. 0.38 0.00 0.00 1.00 
The sequence was therefore Vai-Asp-Pro-Val-Asn-Phe-Lys. 
                     P P P P P 
(11) aTVI-a (Rf Leu 0.16) 
   The following result was obtained by the PTC method. 
            Lys His Asp Ser Ala Val Leu 
composition 1.06 0.94 1.18 0.71 0.97 0.63 0.98 
stage 1 n.d. n.d. 1.15 0.84 1.07 0.00 0.85 
       2 n.d. n.d. 1.16 0.95 0.90 '0.00 0.98 
      3 n.d. n.d. 1.10 0.88 0.08 0.00 0.96 
      4 n.d. n.d. 1.08 0.02 0.00 0.00 0.90 
       5 n.d. n.d. 1.00 0.00 0.00 0.0.0 0.10 
The sequence was determined to be Val-His-Ala-Ser-Leu-Asp-Lys. 
                           P P P P P 
(12) a TVI-b (Rf Leu 0.32) 
   This peptide was digested with pepsin and chromatographed on a 
column (0.9 x 60cm) of Dowex 1X2. As shown in Fig. 5, two peaks 
were obtained.
                        TUBE NUMBER 
Fig. 5. Isolation of the peptic peptides from the tryptic peptide, a TVI-b. 
        Column : Dowex 1 X2, 0.9 x 60 cm.
The effluent at each peak was dried under reduced pressure and puri-
fied by paper chromatography. Two main spots were observed in 
Fig. 6.
      PEAK NUMBER IN FIG. 5 
Fig. 6. Paper chromatogram of the peptic 
       peptides from the tryptic peptide, 
       a TVI-b.
       Table II 
Amino acid composition of 
the peptic peptides from the 
tryptic peptide, a TVI-b 
                PI-a PII-b
    Lys 1.03 
    His 0.97 1.00 
   Arg 
   Cys 
    Asp 1.02 
   Thr 1.06 
    Ser 1.56 
    Glu 1.09 
    Pro 0.97 
   Gly 1.26 
    Ala 1.14 
   Val 
   Met 
    Ileu 0.90 
    Leu 1.05 
    Tyr 0.86 
    Phe 2.10
The amino acid composition of these peptide fragments is given in 
Table II. 
(a) aTVI-b, P-I-a (Rf Leu 0.51) 
            Lys His Asp Ser Glu Gly Ala Ileu Leu 
composition 1.03 0.97 1.02 1.56 1.09 1.26 1.14 0.90 1.05 
stage 1 n.d. n.d. 0.00 1.69 1.08 1.15 1.18 0.89 0.99 
      2 n. d. n. d. 0.00 1.67 1.12 1.15 1.21 0.85 0.12 
      3 n. d. n.d. 0.00 1.07 0.96 1.06 1.07 1.09 0.00 
      4 n.d. n. d. 0.00 1.10 0.99 1.04 1.01 0.90 0.00 
      5 n. d. n. d. 0.00 1.12 1.08 0.10 1.01 0.81 0.00 
      6 n. d. n.d. 0.00 0.10 1.11 0.00 1.03 0.85 0.00 
      7 n.d. n. d. 0.00 0.00 1.11 0.00 0.14 0.89 0.00 
      8 n. d. n. d. 0.00 0.00 0.23 0.00 0.00 1.0'0 0.00 
The sequence was therefore Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Ileu-Lys, 
                                                                       --). .) -) -> 
                     P P P P P P P P
(b) aTVI-b, P-II-b (Rf Leu 0.90) 
            His Thr Pro Tyr Phe 
composition 1.00 1.06 0.97 0.86 2.10 
stage 1 n.d. 0.00 0.91 1.00 2.08 
       2 n.d. 0.010 0.94 0.00 2.06 
      3 n.d. 0.00 1.00 0.00 1.00 
      4 n.d. 0.00 0.00 0.00 1.00 
      5 n.d. 0.00 0.00 0.00 1.00 
The sequence was determined to be Thr-Tyr-Phe-Pro-His-Phe. 
                          P P P P P 
   By combining the above results, the entire sequence of Peptide a 
TVI-b was established as follows; 
Thr-Tyr-Phe-Pro-His-Phe-Asp-Leu-Ser-His-Gly-Ser-Ala-Gln-Ileu-Lys 
           P-II-b -- F-- P-I-a -H 
(13) a TVII-a (Rf Leu 0.35), a TVIII-b (Rf Leu 0.25) 
   These two peptides were mixed and then digested with pepsin. 
The digest was chromatographed on a column (0.9 x 60 cm) of Dowex 
1X2 (200 to 400 mesh). Fig. 7 shows six peaks. The effluent at each
                        TUBE NUMBER 
Fig. 7. Isolation of the peptic peptides from the tryptic peptide, a TVII-a. 
        Column: Dowex 1 X2, 0.9 x 60 cm.
                     PEAK NUMBER IN FIG. 7 
Fig. 8. Paper chromatogram of the peptic peptides from the tryptic peptide, a 
       TVII-a. 
 Trble III Amino acid compositions of the peptic peptides 
          from the tryptic peptide, a TVII-a
        Ia Ib IIa IIc IIIa IVa Va VIa VIb 
Lys 1.01 1.02 1.10 1 
His 0.90 1.00 1.10 1.00 
Arg 
Cys 
Asp 1.83 1.02 1.00 2.01 3.10 0.90 
Thr 0.96 
Ser 1.31 1.92 
Glu 1.15 0.86 1.02 0.88 
Pro 
Gly 0.92 1.03 
Ala 0.97 1.98 1.96 2.13 1.06 1.09 1.08 2.08 1.08 
Val 1.10 0.86 
Met 
Ileu 1.04 0.91 1.04 0.8.0 1.81 1.93 
Leu 0.79 0.90 1.04 1.01 
Tyr 
Phe i
peak was dried under reduced pressure and purified by paper chromato-
graphy. Nine main spots were observed in Fig. 8. 
The amino acid composition of these peptide fragments is given in 
Table III . 
(a) aTVII-a, P-I-a (Rf Leu 0.45) 
   This fragment was analyzed by the PTC method, suggesting that 
the sequence was Ser-Gly-Ala-Leu-Ser-Lys. 
             P P P P 
            Lys Ser Gly Ala Leu 
composition 1.-01 1.31 0.92 0.97 0.79 
stage 1 n.d. 0.08 1.02 1.16 0.98 
      2 n.d. 1.04 0.00 1.07 0.89 
      3 n.d. 1.09 0.00 0.10 0.91 
       4 n.d. 1.00 0.00 0'.00 0.15 
(b) aTVII-a, P-I-b (Rf Leu 0.83) 
   Analysis by the PTC method gave the following result, suggesting 
the sequence was Lys-Val-Ala-Leu-Ala. 
             P P P P 
            Lys Ala Val Leu 
composition 1.02 1.98 1.10 0.90 
stage 1 n.d. 2.01 1.05 0.92 
      2 n.d. 1.88 0.00 1.12 
      3 n.d. 0.90 0.00 1.10 
      4 n.d. 1.00 0.00 0.10 
(c) a TVII-a, P-III-a (Rf Leu 0.22) 
   The following result was obtained by the PTC method. 
            Asp Ala Ileu 
composition 1.02 1.06 0.91 
stage 1 0.21 1.12 0.88 
      2 0.10 0.20 1.00 
The sequence was therefore Asn-Ala-Ileu. 
                                       -4 -4 
                     P P 
(d) a TVII-a, P-IV-a (Rf Leu 0.43) 
   Analysis by the PTC method resulted as follows, suggesting the 
sequence was Ileu-Glu-His-Ala-Asp. 
                     -4 -4 -4 --~ 
          P P P P 
            His Asp Glu Ala Ileu 
Composition 1.00 1.00 0.86 1.09 1.04 
Stage 1 n.d. 1.02 0.84 1.18 0.16 
      2 n.d. 0.80 0.12 1.20 0.00 
      3 n.d. 0.97 0.00 1.03 0.00 
      4 n.d. 1.00 0.00 0.18 0.00
(e) a TVII-a, P-V-a (Rf Leu 0.11) 
   The following result was obtained by the PTC method, suggesting 
the sequence was His -Ala-Asp-Asp-Ileu . 
             P P P P 
            His Asp Ala Ileu 
composition 1.10 2.01 1.08 0.80 
stage 1 n.d. 2.02 1.08 0.82 
      2 n.d. 2.01 0.08 0.98 
       3 n.d. 1.28 0.010 0.81 
      4 n.d. 0.35 0.00 1.00 
(f) aTVII-a, P-VI-b (Rf Leu 0'.98) 
   The followiug result was obtained by the PTC method. 
            Asp Thr Glu Ala Ileu 
composition 0.90 0.96 -0.88 1.08 1.93 
stage 1 0.83 0.87 0.94 1.10 1.01 
      2 0.90 0.00 0.89 1.05 1.101 
     3 0.15 0.00 0.91 1.12 0.94 
      4 0.03 0.00 0.93 0.08 1.05 
      5 0.00 0.00 1.00 0.00 0.05 
The sequence was therefore Ileu-Thr-Asn-Ala-Ileu-Glu. 
                    P P P P P 
   As described above, the sequence of a TVII-a was determined. 
a TVII-a has lysine one residue more than a TVIII-b in the composition. 
This lysine that of a TII-b, and the tryptic digestion could not comple-
tely cleave the linkage between that lysine and a TVIII-b15,,24> Ther-
fore, the entire sequence of a TVIII-b was as presented in Fig. 9.
i 
             Fig. 9. Amino acid sequence in the tryptic peptide, a TVIII-b. 
(14) aTIX-a (Rf Leu 0.23) 
   This peptide was further digested with pepsin, and then the digest 
was subjected to Dowex 1X2 column chromatography. As shown in
                       TUBE NUMBER 
Fig. 10. Isolation of the peptic peptides from the tryptic peptide, aTIX-a. 
         Column: Dowex 1 x 2, 0.9 x 60cm.
                    PEAK NUMBDER IN FIG 10 
Fig. 11. Paper chromatogram of the peptic peptides front the tryptic peptide, aTIX-a.
Fig. 10, six peak were obtained. The effluent at each peak was dried 
under reduced pressure and then purified by paper chromatography. 
Five main spots were detected. 
The amino acid composition of these peptide fragments is summarized 
in Table IV. 
    Table IV Amino acid compositions of the peptic peptides 
             from the tryptic peptide, a TIX-a
          Ib IIa IVa Vb VC 
Lys 
His 0.99 
Arg 0.98 0.95 
Cys 
Asp 
Thr 0.84 0.88 
Ser 
Glu 1.03 1.09 1.81 1.15 1.05 
Pro 
Gly 1.08 1.13 1.13 




Leu 1.09 1.05 
Tyr 0.71 0.75 
Phe
(a) a TIX-a, P-II-a (Rf Leu 0.59) 
   The following result was obtained by the PTC method, suggesting 
the sequence was Thr-Leu-Glu-Arg. 
             P P 
            Arg Thr Glu Leu 
composition 0.95 0.84 1.09 1.05 
stage 1 n.d. 0.00 1.04 0.96 
      2 n.d. 0.00 1.00 0.06 
(b) a TIX-a, P-IV-a (Rf Leu 0.43) 
   This fragment was analyzed by the PTC method as follows. 
            His Glu Gly Ala Ileu 
composition 0.99 1.81 1.08 2.11 0.96 
stage 1 n.d. 2.05 1.04 1.90 0.00 
      2 n.d. 2.00 0.94 1.05 0.00 
      3 n.d. 2.01 0.26 0.96 0.00 
      4 n.d. 1.90 0.00 1.03 0.00 
      5 n.d. 2.00 0.00 0.00. 0.00
The sequence was determined to be Ileu-Ala-Gly-His-Ala-Glu-Glu, 
                           P P P P P 
(c) a TIX-a, P-V-b (Rf L eu 0.68) 
   Analysis by the PTC method gave the following result, suggesting 
the sequence was Tyr-Gly-Ala-Glu-Thr. 
              > > 
             P P P P 
            Thr Glu Gly Ala Tyr 
composition 0.88 1.15 1.13 1.12 0.71 
stage 1 0.82 1.08 1.05 1.04 0.00 
      2 0.83 1.11 0.00 1.05 0.00 
      3 0.92 1.08 0.00 0.00 0.00 
      4 1.00 0.08 0.00 0.00 0.00 
   By combining the above results from the peptide fragments toge-
ther, the entire sequence of a TIX-a was determined as shown in Fig. 
12.
                Fig. 12. Amino acid sequence in the tryptic peptide, aTIX-a 
 8) Determination of the N-Terminal Residue of the Lpsoluble Tryptic Peptide by 
    the DNP Method. 
    The N-terminal residue of the insoluble tryptic peptide was known 
 to be leucine by the DNP method. 
 9) Column Chromatography, Paper Chrcrnatogi afhy, and Amino Acid 
    Composition of Peptic Peptides from the Insoluble Tryptic Peptide. 
    Five peaks are observed in Fig. 13. The effluent at each peak was 
 dried under reduced pressure and purified by paper chromatography. 
 As shown in Fig. 14, eight main spots were obtained. The amino 
 acid composition of these spots is given in Table V. 
 10) Amino Acid Sequence of the Peptic Peptides from the Insoluble Tryptic 
    Peptide 
(1) P-I-b (Rf Leu 0.36)
                    TUBE NUMBER 
Fig. 13. Isolation of the peptic peptides from the insoluble tryptic peptide
                     PEAK NUMBER IN FIG. 13 
Fig. 14. Paper chromatogram of the peptic peptides from the insoluble tryptic 
       peptide.
Table V Amino acid compositions of the peptic peptides 
        from the insoluble tryptic peptide
          lb Ha IIIa IIIb IIIc IIId I Va Va 
Lys 0.88 1.01 1.01 
His 1.12 1.03 
Arg 
Cys + + 
Asp 1.01 
Thr 0.96 0.96 0.83 
Ser 0.96 
Glu 0.89 1.08 
Pro 0.97 1.05 
Gly 1.05 1.06 1.17 
Ala 2.03 1.04 2.03 1.16 
Val 0.98 0.97 1.98 2.25 1 .96 
Met 
lieu 
Leu 1.07 1.03 1.04 1.01 1.85 1.94 1.97 
Tyr 
Phe 0.90 0.89
   Analysis by the PTC method resulted as follows. 
            Lys His Pro Ala Val Leu 
composition 0.88 1.12 0.97 2.03 0.98 1.07 
stage 1 0.98 1.02 0.95 2.08 0.99 0.08 
      2 0.96 1.03 1.07 1.01 0.92 0.00 
      3 0.98 1.03 0.18 1.00 0.93 0.0'0 
      4 0.10 0.98 0.00 1.00 0.92 0.00 
      5 0.00 0.99 0.00 1.00 0.10 0.00 
      6 0.00 0.15 0.00 1.00 0.010 0.00 
The sequence was therefore determined to be Leu-Ala-Pro-Lys-Val-His-
Ala. P P P P P P 
(2) P-II-a (Rf Leu 0.32) 
   The following result was obtained by the PTC method, :suggesting 
the sequence was Thr-Ala-Lys. 
             P P
            Lys Thr Ala 
composition 1.01 0.96 1.04 
stage 1 n.d. 0.12 1.00 
      2 n.d. 0.00 0.15 
(3) P-III-a (Rf Leu 0.37) 
   This peptide fragment was analyzed by the PTC method as follows.
            His Glu Pro Ala Val Leu 
composition 1.03 0.89 1.05 2.03 0.97 1.03 
stage 1 n. d. 0.91 1.04 2.04 0.05 1.02 
      2 n.d. 0.92 1.05 1.03 0.00 1.01 
      3 n.d. 0.88 1.05 1.03 0.00 0.85 
      4 n.d. 0.95 0.91 1.02 0.00 0.10 
      5 n.d. 0.94 0.11 1.06 0.00 0.00 
      6 n.d. 1.00 0.00 0.16 0.00 0.00 
The sequence was therefore determined to be Val-Ala-His-Leu-Pro-Ala-
                                                                                              --~- - --± - * --> ---). 
Glu. P P P P P P 
(4) P-III-b (Rf Leu 0.78) 
   The N-terminal amino acid was known to be serine by the DNP 
method, suggesting the sequence was Ser-Leu. 
D 
(5) P-III-c (Rf Leu 0.86) 
   Analysis by the PTC method resulted as follows. 
            Thr Gly Val Leu 
composition 0.96 1.05 1.98 1.01 
stage 1 0.98 1.04 1.01 1.02 
      2 0.96 0.13 1.02 1.02 
      3 0.08 0.00 0.98 1.01 
      4 0.00 0.00 0.15 1.00 
The sequence was therfore determined to be Val-Gly-Thr-Val-Leu 
                                P P P P
(6) P-III-d (Rf Leu 1.00) 
   The following result was obtained by the PTC method. 
            Val Leu 
composition 2.25 1.85 
stage 1 2.03 0.97 
      2 1.06 0.94 
      3 0.18 1.00 
The sequence was therefore Leu-Val-Val-Leu. 
                     P P P 
(7) P-IV-a (Rf Leu 0.92) 
   Analysis by the PTC method resulted as follows. 
            Cys Glu Gly Leu Phe 
composition + 1.08 1.06 1.94 0.90 
stage 1 + 1.09 0.97 0.99 0.93 
      2 + 1.10 1.01 0.11 0.89 
      3 + 1.04 0.10 0.010 0.96
      4 + 0.28 0.00 0.00 1.00 
       5 - 0-.00 0.00 '0.00 1.00 
The sequence was therefore Leu-Leu-Gly-Gln-Cys-Phe. 
                     > > > 
                     P P P P P 
(8) P-V-a (Rf Leu 0.75) 
            Lys Cys Asp Thr Gly Ala Val Leu Phe 
composition 1.01 + 1.01 0.83 1.17 1.16 1.96 1.97 0.89 
stage 1 n . d . + 0.05 0.90 1.15 1.10 1.98 1.98 0.91 
      2 n.d. + 0.00 0.89 1.16 1.09 1.99 2.01 0.92 
      3 n.d. + 0.00 0.91 1.13 1.09 1.98 2.00 0.08 
      4 n.d. + 0.00 0.91 1.10 1.11 1.97 1.01 0.00 
      5 n.d. - 0.00 0.88 1.08 1.06 1.98 1.02 0.00 
      6 n.d. - 0.00 0.90 1.06 0.10 1.98 1.02 0.00 
      7 n.d. - 0.00 0.91 1.05 0.00 1.03 1.01 0.00 
The above result obtained by the PTC method suggests the sequence 
was Asp-Lys-Phe-Leu-Cys-Ala-Val-(Gly, Thr, Val, Leu). 
    P P P P P P P 
   Since Peptide P-III-c corresponds to the C-terminal portion of this 
fragment, the sequence of P-V-a was determined to be Asp-Lys-Phe-
Leu-Cys-Ala-Val-Gly-Thr-Val-Leu. 
   By combining the above results together, the whole sequence of 
the insoluble tryptic peptide was determined as shown in Fig. 15.
Leu-Leu-GIy-GIn-Cys-Phe- Leu-Val-VaI-Leu-Val-Ala-His- Leu-Pro-Ala- Glu-Leu-Ala-Pro 
       PIV-a PIII-d P111-a                                  -~
Lys-Val-His-Ala-Ser-Leu-Asp-Lys-Phe-Leu-Cys-Ala-Val-Gly-Thr-Val-Leu-Thr-Ala-Lys 
- PI-b P111-b P111-c PII-a 
                                            PV- a
              Fig. 15. Amino acid sequence in the insoluble tryptic peptide. 
                   DISCUSSION 
   Concerning the the components of adult white leghorn hemoglobin, 
FASNEIZ, is), SAHA, 42) , and HUSIMAN48) reported that the hemoglobin consi-
sted of two kinds of components. However, MATSUDA321 and D' AMELOIG) 
proposed that it was composed of three kinds of compnents. MANVVELL28j
stated in his report that the older hemoglobin samples often showed a 
broadeding of the acidic minor component hemoglobin zone, frequently 
showing subdivision into two or more diffuse bands. This phenomenon 
was also observed in the present experiment. However, it is yet un-
known why the number of the components differs thus among investi-
gators. 
   It turned out by the present experiment that adult white leghorn 
hemoglobin contained two residues of cysteine in the a polypeptide 
chain. This fact is in agreement with the report of SAHA et al. 43) on 
the amino acid composition. However, the estimation of cysteine resu-
lted in 1.40 mole per one molecule of the a polypeptide chain, probably 
because the a polypeptide chain had not dissolved completely in the 
process of the oxidation with performic acid. Incidentally, no hemo-
globins so far studied contain two or more cysteine residues in their a 
polypeptide chains. 
   As for tryptophan residues, the estimation resulted in 0.14 mole 
per one molecule of the a polypeptide chain. According to KOSHLAND et 
al.3) this result indicates that no residue of tryptophan was contained 
in the a polypepide chain of adult white leghorn hemoglobin. In addi-
tion, no tryptophan residues were found in the process of the sequence 
determination. HILSMANN et al.") stated in their paper on the fragments 
from the a polypeptide chain of llama hemoglobin that the tryptophan 
residue at Position 14 in human hemoglobin was replaced by Pheny-
lalanine in llama hemoglobin. 
    Tadle VI Amino acid sequence in the soluble tryptic peptides 
             from the a polypeptide chain of All component 
            of adult white leghorn hemoglobin.













                Lys 
aTVIII-b Val-Ala-Leu-Ala-Ileu-Thr-Asn-Ala-Ileu-Glu-His-Ala-Asp-Asp-Ileu-
                       Ser-Gly-Ala-Leu-Ser-Lys 
aTlx-a Ileu-Ala-Gly-His-Ala-Glu-Glu-Tyr-Gly-Ala-Glu-Thr-Leu-Glu-Arg
   The amino acid sequences in all the tryptic peptides from the a 
polypeptide chain of adult white leghorn hemoglobin was established by 
the present investigation as shown in Table VI. 
These results are discussed by comparing with the known sequence of 
human hemoglobin. First, it is known that the sequeuce in the five 
tryptic peptides, a TI-a, a TII-a, a TII-b, a TIII-c, and a TV-b are quite 
similar to those in a T10, a T7, a T8, a T14, and a Tll of human hem-
oglabin, respectively. Peptide a TIV-d seems to correspond to a T3 of 
human hemoglobin, however, in the sequence analysis, four of the 
five residues are different from each other. This peptide was in high 
yield and occupied constantly the same position both on the column 
and paper chromatograms, suggesting that it is not a contamination. 
Peptide a TV-a has quite the same sequence with Position 83 to 90 in 
the a polypeptide chain of human hemoglobin, which accounts for the 
C-terminal portion of a T9. Peptide a TVI-a has the identical sequence 
with Position 121 to 127 in the a polypeptide chain of huma hemoglobin, 
which accounts for the C-terminal portion of a T12. Similarly, aTIII-b, 
a TIII-d, a TIV-a, a TVI-b, a TVIII-b, and a TIX-a are presumed to 
correspond to a T2, a T5, a T1, a T6, the N-terminal portion of a 
T9, and a T4, respectively. 
   BRAUNITZER et al. 10,111, in their study on human hemoglobin, ob-
tained the "core" peptide in which Lys-Phe linkage was not cleaved, 
whereas KONIGSBERG et al."') , 241 succeeded in cleaving this linkage. In 
the present investigation were obtained both kinds of these peptides, 
that is, aTVI-a in which Lys-Phe linkege was cleaved, and the a core 
P-V-a in which the linkage was not cleaved. 
   In the PTC degradation method, removal of glycine, asparagine, 
and aspartic acid residues was not successful. KONIGSBERG et al .49' also 
described about this fact and presumed that it was probably because 
the formation of phenylisocarbamyl peptides prevented them from cy-
clization. 
   PERUTZ37I and BRAUNITZER et al.7' brought forward a hypothesis that 
there exist eight invariable residues common to hemoglobins from var-
ious kinds of species and that they were glycine at B6, proline at C2, 
phenylalanine at CD1, histidine at E7, leucine at F4, histidine at F8, 
lysine at H10, and tyrosine at H23. It was confirmed by the present 
investigation that amino acid replacement was not observed at the 
above-mentioned eight positions in white leghorn hemoglobin. 
   Furthermore, PERUTZ37) proposed the rule of isopolar substitution 
that 33 positions of the internal site and 10 positions of the surface 
cervices were occupied by non-polar residues. In application of this 
rule to the results obtained by the present investigation, the amino acid 
substitutions in the internal site between human and white leghorn 
hemoglobin which were found at seven positions, All, A12, A15, B9, E4, 
E15, and E19 were all among non-polar residues with the exception
of B9, which was a non-polar residue, alanine, in human hemoglobin 
but apolar-residue. threonine, in white leghorn hemoglobin. This is 
considered to be one of the three exceptions pointed out by PERUTZ et 
al. 37) , who stated that in some cases B9 was occupied by threonine or 
serine which was probably hydrogen-bonded internally. 
   Concerning the correlation between amino acid substitution and 
gene, BEAL et a1.5' explained that one amino acid substitution in abn-
ormal human hemoglobin was caused by single base change in the tri-
plet coden in gene which controls hemoglobin biosynthesis. According 
to the amino acid triplet coden proposed by NIERENBERG35' , 21 of 35 
amino acid substitutions in the a polypeptide chain between human 
and white leghorn hemoglobins, that is, the amino acid substitutions 
at Positions 8, 12, 17, 18, 19, 22, 28, 34, 55, 66, 70, 71, 73, 76, 102, 
103, 105, 110, 117, 118, and 133, are presumed to be due to single base 
change in the triplet code; the remaining 14 amino acid substitutions, 
that is, those at Position 4, 13, 14, 15, 35, 64, 77, 78, 82, 108, 120, 
130, 131, and 138 are presumed to be due to double base change. 
   FLORKIN19' stated that according as animals evolve higher, their 
hemoglobins in general contain less histidine and tryptophan and that 
hemoglobins of higher animals contain almost no isoleucine and few 
methionine. It turned out by the present investigation that white leg-
horn hemoglobin contained seven isoleucine residues, whereas human 
hemoglobin has no isoleucine residues. However, the former has histi-
dine, methionine, and tryptophan one residue less than the latter. 
This fact is contrary to the above-described FLORKIN'S view. 
                   CONCLUSION 
   The sequence in all the tryptic peptides from the a polypeptide chain 
of adult white leghorn hemoglobin was determined. The results were 
discussed in comparison with the known sequence in the a polypeptide 
chain of human hemoglobin. Amino acid substitution was found at 35 
positions between the two hemoglobins. Furthermore, it is confirmed 
that these substitutions are compatible with PERUTZ' S view of eight 
invariable residues in hemoglobins as well. as to his rule of non-polar 
substitution. 
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